EXPLOITING DIVERSE DATA SOURCES TO INVESTIGATE EMERGING SAFETY ISSUES OF DRUGS IN POST-MARKETING PHASE: A RESEARCH FRAMEWORK FOR CLINICAL PHARMACOLOGIST